Stay updated on IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page.

Latest updates to the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check15 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check58 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference0.9%
- Check65 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check108 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page.